USIDNET- LeBien Visiting Professor

The LeBien Visiting Professor Program promotes improved knowledge about the diagnosis and treatment of primary immunodeficiency diseases. Teaching hospitals throughout the United States may submit a request for a leading clinical immunologist to lead Grand Rounds or present at other educational activities, such as bedside rounds or house staff and/or medical residents conferences.

If you are interested in participating in this exciting program, please send a brief (one page) letter to the Immune Deficiency Foundation, Attn: IDF & USIDNET LeBien Visiting Professor Program, 40 West Chesapeake Ave., Suite 308, Towson, MD 21204 by November 30, 2012, stating your desire to participate in the program. The letter should include a tentative list of teaching and clinical activities for the Visiting Professor and information on how your training program would benefit from a Visiting Professorship.
The benefits of the USIDNET/IDF's (IDF & USIDNET’s) LeBien Visiting Professor Program include:
• Increases knowledge of the diagnosis and treatment of primary immunodeficiency diseases
• Expert clinical immunologists to lead grand rounds and other educational activities
• Available to teaching hospitals throughout the United States
• Professional medical educational materials to accompany the program
2012 Lebien Visiting Professor Schedule

Visiting Professor 2012
Advocate Hope Children’s Hospital
August 1
Steven Holland, MD
Children’s Mercy Hospitals and Clinics/ University of Missouri-Kansas City School of Medicine
March 26
Steven Holland, MD
Geisinger Health System
September 18
John Routes, MD
Mass General Hospital for Children
October 1
Mary Ellen Conley, MD
Miami Children’s Hospital
November 16
Mary Ellen Conley, MD
Quillen College of Medicine
September 4
Kathleen Sullivan, MD, PhD
St. Luke’s Children Hospital
October 16
Troy Torgerson , MD, PhD

For more information, contact Diana Gill at 443-632-2545 or email
The LeBien Visiting Professor Program is funded in part by the IDF Core Service Sponsors: Baxter Healthcare Corporation, CSL Behring, Grifols, IgG America / ASD Healthcare, Octapharma and Talecris Biotherapeutics, as well as the United States Immunodeficiency Network (USIDNET).

The United States Immunodeficiency Network, (USIDNET) a program of the Immune Deficiency Foundation (IDF) is funded in part by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH) an agency of the Department of Health & Human Services. NIAID supports research to advance the understanding of transplantation and to prevent, diagnose and treat infections and Immune-mediated illnesses. USIDNET administrative support is provided by the
Immune Deficiency Foundation (IDF).